Fulgent Genetics, a leading player in the genetic testing industry, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a key provider of comprehensive genomic solutions, focusing on areas such as hereditary cancer testing, infectious disease testing, and pharmacogenomics. Fulgent's innovative approach combines advanced technology with a broad test menu, offering unique, customisable panels that cater to diverse clinical needs. The company has achieved significant milestones, including partnerships with healthcare providers and laboratories, enhancing its market position. With a commitment to accuracy and efficiency, Fulgent Genetics continues to drive advancements in precision medicine, making a notable impact in the field of genomics.
How does Fulgent Genetics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Fulgent Genetics's score of 43 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Fulgent Genetics reported total carbon emissions of approximately 4,528,000 kg CO2e, comprising 576,000 kg CO2e from Scope 1 and 3,953,000 kg CO2e from Scope 2 emissions. This marks a significant reduction from 2022, where total emissions were about 6,562,000 kg CO2e, with Scope 1 emissions at 2,130,000 kg CO2e and Scope 2 at 4,433,000 kg CO2e. In 2021, the company emitted around 3,101,000 kg CO2e, with Scope 1 and Scope 2 emissions of 1,651,000 kg CO2e and 1,450,000 kg CO2e, respectively. Fulgent Genetics has set ambitious climate commitments, aiming to achieve net zero emissions by 2050. The company has also pledged to reduce its emissions by 45% by 2030, using 2010 levels as a baseline. These targets reflect a comprehensive approach to sustainability, addressing all scopes of emissions. The emissions data is not cascaded from any parent organization, indicating that Fulgent Genetics is independently reporting its carbon footprint and climate initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,651,000 | 0,000,000 | 000,000 |
| Scope 2 | 1,450,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fulgent Genetics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
